Loading…

6508 ORAL CP-751, 871, an anti-IGF-IR antibody, in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC): A phase Ib/randomized phase II, non-comparative, open label trial

Saved in:

Bibliographic Details
Published in:	European journal of cancer supplements 2007, Vol.5 (4), p.358-359
Main Authors:	Paz-Ares, L, Pollak, M.N, Eisenberg, P.D, Blakely, L.J, Haluska, P, Cohen, R.B, Kreisman, H, Melvin, C, Gualberto, A, Karp, D
Format:	Article
Language:	English
Subjects:	Hematology, Oncology and Palliative Medicine
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!